|1.||Milgrom, E: 2 articles (06/2001 - 01/2000)|
|2.||Marino, Marco: 1 article (12/2015)|
|3.||Casarini, Livio: 1 article (12/2015)|
|4.||Santi, Daniele: 1 article (12/2015)|
|5.||Rey, Florencia: 1 article (12/2014)|
|6.||Ortega, Hugo H: 1 article (12/2014)|
|7.||Marelli, Belkis E: 1 article (12/2014)|
|8.||Salvetti, Natalia R: 1 article (12/2014)|
|9.||Diaz, Pablo U: 1 article (12/2014)|
|10.||Heublein, Sabine: 1 article (01/2012)|
09/15/2004 - "Gonadotropin receptors are expressed not only in the gonads, but also in non-gonadal tissues and in cancer cells. "
11/01/1999 - "Whether activating mutations of the gonadotropin receptors are involved in tumor development is not yet clear. "
01/01/1981 - "Several clonal lines of cultured Leydig tumor cells have been established and characterized in terms of gonadotropin receptors and steroid production. "
01/01/1981 - "Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses."
08/01/1977 - "Gonadotropin receptors in experimentally induced ovarian tumors in mice."
|3.||Hypogonadism (Hypergonadotropic Hypogonadism)
01/01/2000 - "In the case of alterations of gonadotropin receptors the hypogonadism is hypergonadotrophic. "
01/01/1988 - "Testicular gonadotropin receptors in men with hypogonadotropic hypogonadism."
11/01/1984 - "To evaluate the hypothesis that the hypogonadism might be the result of circulating antibodies to gonadotropin receptors or to an abnormal gonadotropin molecule, a series of clinical and laboratory studies was carried out. "
|5.||Ovarian Neoplasms (Ovarian Cancer)
06/01/2004 - "Ovarian cancer cell lines and tissues express gonadotropin receptors. "
01/01/2012 - "Glycodelin was correlated to expression of gonadotropin receptors and mucin-1, which are discussed as ovarian cancer tissue markers. "
01/01/2011 - "Since a substantial percentage of ovarian cancers express gonadotropin receptors and are responsive to the relatively high concentrations of pituitary gonadotropins during the postmenopausal years, it has been suggested that receptor activation may contribute to the etiology and/or progression of the neoplasm. "
|5.||Thyrotropin Receptors (Thyrotropin Receptor)
|6.||Chorionic Gonadotropin (Human Chorionic Gonadotropin)
|8.||Protein Isoforms (Isoforms)
|9.||GTP-Binding Proteins (G-Protein)